We are live on
!
Find out more
SAM
Shell Asset Management Portfolio holdings
AUM
$996M
1-Year Est. Return
26.19%
This Fund
S&P 500
This Quarter
Est. Return
+13.98%
1 Year Est. Return
+26.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.9B
AUM Growth
+$790M
(+37%)
Cap. Flow
+$530M
Cap. Flow
% of AUM
18.28%
Top 10 Holdings %
Top 10 Hldgs %
32.57%
Holding
1,285
New
25
Increased
484
Reduced
690
Closed
18
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$32.5M |
| 2 |
Microsoft
MSFT
|
+$31.2M |
| 3 |
Apple
AAPL
|
+$29.5M |
| 4 |
Amazon
AMZN
|
+$19.7M |
| 5 |
Meta Platforms (Facebook)
META
|
+$14M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DFS
Discover Financial Services
DFS
|
+$3.74M |
| 2 |
Celestica
CLS
|
+$2.56M |
| 3 |
StoneX
SNEX
|
+$1.81M |
| 4 |
Agnico Eagle Mines
AEM
|
+$1.41M |
| 5 |
Monolithic Power Systems
MPWR
|
+$1.19M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.47% |
| 2 | Financials | 14.34% |
| 3 | Consumer Discretionary | 11.01% |
| 4 | Healthcare | 9.23% |
| 5 | Industrials | 8.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VERV
1101
DELISTED
Verve Therapeutics
VERV
| $65K | ﹤0.01% |
5,806
| – | – |
|
1102
Viking Therapeutics
VKTX
$3.93B
| $65K | ﹤0.01% |
2,458
-270
| -10% | -$7.11K |
|
|
SA
1103
Seabridge Gold
SA
$2.69B
| $64K | ﹤0.01% |
4,412
+300
| +7% | +$3.81K |
|
1104
NovaGold Resources
NG
$2.55B
| $63K | ﹤0.01% |
15,389
+1,100
| +8% | +$4.12K |
|
1105
RH
RH
$3.36B
| $63K | ﹤0.01% |
334
-37
| -10% | -$6.87K |
|
1106
RLX Technology
RLX
$2.43B
| $63K | ﹤0.01% |
28,411
| – | – |
|
1107
First Advantage
FA
$3.58B
| $62K | ﹤0.01% |
3,733
-418
| -10% | -$6.75K |
|
1108
Vaxcyte
PCVX
$7.88B
| $62K | ﹤0.01% |
1,910
-210
| -10% | -$6.88K |
|
1109
RingCentral
RNG
$4.77B
| $62K | ﹤0.01% |
2,187
-240
| -10% | -$6.19K |
|
1110
AngioDynamics
ANGO
$593M
| $61K | ﹤0.01% |
6,169
-4,639
| -43% | -$45.4K |
|
1111
BlackLine
BL
$1.87B
| $61K | ﹤0.01% |
1,076
-119
| -10% | -$6.15K |
|
1112
Columbia Sportswear
COLM
$3.3B
| $60K | ﹤0.01% |
983
-107
| -10% | -$6.88K |
|
1113
Evolent Health
EVH
$421M
| $60K | ﹤0.01% |
5,288
-568
| -10% | -$5.22K |
|
1114
Inter&Co
INTR
$2.47B
| $60K | ﹤0.01% |
+8,116
| New | +$53.9K |
|
1115
Packaging Corp of America
PKG
$22.6B
| $60K | ﹤0.01% |
319
-3,275
| -91% | -$619K |
|
1116
United Natural Foods
UNFI
$3.07B
| $60K | ﹤0.01% |
2,587
-280
| -10% | -$7.3K |
|
1117
Avnet
AVT
$7.07B
| $59K | ﹤0.01% |
1,112
-117
| -10% | -$5.81K |
|
1118
L3Harris
LHX
$56.9B
| $59K | ﹤0.01% |
+234
| New | +$53.8K |
|
1119
Vermilion Energy
VET
$1.59B
| $59K | ﹤0.01% |
8,092
+300
| +4% | +$2.05K |
|
1120
Alaska Air
ALK
$5.42B
| $58K | ﹤0.01% |
1,173
-130
| -10% | -$6.32K |
|
|
JKS
1121
JinkoSolar
JKS
$782M
| $58K | ﹤0.01% |
2,710
| – | – |
|
1122
California Water Service
CWT
$3.14B
| $57K | ﹤0.01% |
1,246
-142
| -10% | -$6.79K |
|
1123
MGE Energy Inc
MGEE
$3.09B
| $57K | ﹤0.01% |
646
-71
| -10% | -$6.39K |
|
1124
AMN Healthcare
AMN
$1.35B
| $56K | ﹤0.01% |
2,723
-300
| -10% | -$6.24K |
|
1125
Bio-Rad Laboratories Class A
BIO
$8.86B
| $56K | ﹤0.01% |
234
-26
| -10% | -$6.15K |
|
Similar funds
BFS
IAM
BCM
NSEDCP
MSAM
BA
CP
WCWM
Shell Asset Management's Q2 2025 Portfolio in Review
As of Q2 2025, Shell Asset Management held 1,285 positions worth $2.9B, up 37% from $2.11B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Shell Asset Management deployed $530M of net new capital in Q2 2025, opening 25 new positions and adding to 484 existing holdings. Its largest new stake was Globus Medical: 7,947 shares worth $469K.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 30% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Celestica, an estimated $2.56M trimmed.
- Shell Asset Management's largest Q2 2025 buy was Globus Medical: 7,947 shares worth $469K.
- Shell Asset Management added most to NVIDIA in Q2 2025, an estimated $32.5M increase.
- Shell Asset Management's biggest Q2 2025 reduction was Celestica, cutting an estimated $2.56M.
- Shell Asset Management fully exited Discover Financial Services in Q2 2025, selling an estimated $3.74M.
- Shell Asset Management's ten largest holdings make up 33% of its $2.9B portfolio in Q2 2025.
- Shell Asset Management opened 25 new positions and closed 18 in Q2 2025.
- Shell Asset Management's portfolio value rose 37% quarter-over-quarter to $2.9B.
Based on Shell Asset Management's 13F filing for Q2 2025, filed 23 Jul 2025.